Correction to: Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2)

Simpson, EricEricSimpsonFernández-Peñas, PabloPabloFernández-Peñasde Bruin-Weller, MarjoleinMarjoleinde Bruin-WellerLio, Peter A.Peter A.LioCHIA-YU CHUet al.2025-07-012025-07-012024-12-05https://scholars.lib.ntu.edu.tw/handle/123456789/730410enCorrection to: Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2)other10.1007/s12325-024-03010-939636571